Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-14-052227)

Filing Details

Accession Number:: 0001209191-14-052227
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-08-13 17:36:41
Reporting Period:: 2014-08-11

Filing Date:: 2014-08-13
Accepted Time:: 2014-08-13 17:36:41
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1087432	Intermune Inc	ITMN	Pharmaceutical Preparations (2834)	943296648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1212689	John Hodgman	3280 Bayshore Blvd Brisbane CA 94005	Evp, Finance & Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2014-08-11	4,724	$43.05	18,843	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The transaction was made pursuant to the terms of the 10b5-1 plan in effect at the time of the transaction.
Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $43.00 to $43.31 per share. Full information on the numbers of shares sold at each sale price is available upon request.